Litigation Details for Cadence Pharmaceuticals Inc. v. Agila Specialties Inc. (D. Del. 2014)
✉ Email this page to a colleague
Cadence Pharmaceuticals Inc. v. Agila Specialties Inc. (D. Del. 2014)
| Docket | See Plans and Pricing | Date Filed | 2014-12-18 |
| Court | District Court, D. Delaware | Date Terminated | 2017-01-11 |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | Referred To | ||
| Patents | 6,028,222; 6,992,218 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Cadence Pharmaceuticals Inc. v. Agila Specialties Inc.
The small molecule drug covered by the patents cited in this case is See Plans and Pricing .
Details for Cadence Pharmaceuticals Inc. v. Agila Specialties Inc. (D. Del. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2016-08-29 | 147 | alleging infringement of U.S. Patent Nos. 6,028,222 (the '" 222 patent") and 6,992,218 (the…the "'218 patent"). The patents claim aqueous acetaminophen formulations and methods of…; It is a bedrock principle of patent law that the claims of a patent define the invention to which the…reading the entire patent." Id. at 1321 (internal quotation marks omitted). The patent specification …ultimate question of the proper construction of a patent is a question oflaw. See Teva Pharm. USA, Inc. | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
